SGI Enhanced Nasdaq-100 ETF (QXQ)
The SGI Enhanced Nasdaq-100 ETF (NASDAQ: QXQ) holds the same 100 large-cap stocks as the standard Nasdaq-100 index, but reweights them based on fundamental quality metrics. Instead of holding each stock in proportion to its market capitalization — which means the largest and most expensive stocks dominate — QXQ emphasizes companies with strong profitability, high returns on capital, and durable competitive positions. The result is a portfolio that looks like the Nasdaq but tilted toward substance over size.
Nasdaq-100 stocks include the largest technology companies, internet platforms, and biotech firms. Apple and Microsoft are enormous and dominate a market-cap-weighted index. QXQ keeps all 100 stocks but shifts weight: a highly profitable pharmaceutical company with improving fundamentals gets more of the portfolio, while a mega-cap tech company with slowing earnings growth gets less. It is still the Nasdaq-100, but rearranged to reward quality.
The philosophy behind the reweighting
An index weighted by market capitalization is mathematically efficient but fundamentally agnostic about quality. Coca-Cola and a struggling soda company could theoretically coexist; the only thing that matters for weighting is their market price. Academic research going back decades has documented a quality effect: stocks with high return on equity, stable earnings, strong balance sheets, and durable competitive advantages tend to outperform the broader market over long periods. This is not guaranteed in any short period, and quality can underperform for years when speculation or momentum dominates. But over 20-year periods, quality has been a reliable factor.
QXQ mechanically tilts toward these quality characteristics without trying to forecast which companies will succeed. Stocks are scored on measures such as return on equity (profits relative to shareholder capital), profit margins, earnings stability, and balance-sheet strength. High-scoring stocks get overweighted; lower-scoring stocks get underweighted. The fund never removes any of the 100 Nasdaq stocks from the portfolio — it just redistributes the weights based on these criteria.
What this means in practice
The practical effect is that QXQ often overweights different companies than a conventional Nasdaq-100 fund. A mega-cap company that is profitable and stable might carry 6 percent of the portfolio in QXQ versus 8 percent in the cap-weighted index. A mid-sized company with superior profitability and high return on equity might rise from 0.8 percent to 1.2 percent. The shifts are often subtle in percentage terms but compound over years of performance.
This also means QXQ is not a pure Nasdaq-100 play. It correlates highly with the Nasdaq-100 — both own the same 100 stocks and move broadly in sync — but the quality tilt creates a different return profile. When quality is out of favor and investors are chasing hot growth stocks, QXQ may lag. When disciplined fundamentals matter, QXQ tends to pull ahead.
The cost of enhancement
QXQ charges an expense ratio higher than a plain Nasdaq-100 ETF because it requires scoring companies on quality metrics and reweighting the portfolio regularly — typically quarterly or semi-annually. That cost is embedded in the fund’s returns; an investor does not pay it directly, but it reduces the fund’s performance relative to what it would be without fees. For the enhancement strategy to justify the cost, the quality tilt must add value net of expenses over a reasonable period — typically three to five years or longer.
Additionally, the reweighting process creates some turnover. Quarterly reconstitution generates trading costs and the realization of capital gains if held in a taxable account. These costs are smaller than in a fully active fund but more than in a purely passive market-cap index.
Risks and limitations
A key risk is that quality enhancement is a bet on a factor that can underperform for extended periods. Between 2010 and 2020, for instance, high-growth, high-valuation stocks — the opposite of quality — dramatically outperformed. A quality-tilted portfolio would have lagged the market substantially. That is not a permanent drag, but it is painful while it lasts, and no investor can reliably predict when quality will regain favor.
Concentration is another consideration. The Nasdaq-100 is already tilted heavily toward technology, internet, and growth-oriented sectors. QXQ’s quality tilt means it will emphasize the profitable, durable tech and internet companies while reducing weight on lower-quality or more speculative ones. This still leaves the portfolio heavily exposed to technology sector risks.
The 100-stock universe itself is concentrated. QXQ cannot broaden its holdings beyond the Nasdaq-100, so it cannot diversify away from the Nasdaq’s sector tilts or factor tilts. An investor seeking exposure to quality should consider whether the Nasdaq is the right starting universe or if a broader quality fund would serve better.
Who QXQ is designed for
QXQ suits investors who believe in the quality factor — that profitable, well-managed companies with durable advantages deserve a place in any serious portfolio — and who want that exposure tilted toward large-cap growth names. It is a good fit for investors who already own a Nasdaq-100 fund and want to transition to a more fundamental approach without leaving the large-cap tech and internet ecosystem.
QXQ is less suitable for investors seeking the purest, cheapest exposure to the Nasdaq-100. If your goal is to own the Nasdaq-100 exactly as it exists, a standard market-cap-weighted Nasdaq-100 ETF is simpler and cheaper. QXQ is for those willing to pay a modest fee and accept some factor risk in exchange for a conviction that quality matters.
Evaluating the fund
Investors should compare QXQ’s returns to a standard Nasdaq-100 ETF over multiple time periods — one year, three years, five years — to see whether the quality tilt has added value net of fees. Review the fund’s methodology document to understand precisely which metrics drive the quality scoring. Check the fund’s factsheet to see which stocks are overweighted versus the cap-weighted index; this reveals the fund’s actual bets. Over a full market cycle including a quality drawdown period, this comparison illuminates whether the enhancement strategy is delivering what it promises.